
Grupo Jayor

Grupo Jayor
From our plants to your market
From our plants to nine countries.
By the numbers
in products sold
A measure of trust earned, market by market.
What we do
We manufacture, distribute and innovate. Grupo Jayor brings together parenteral manufacturing plants in Argentina and El Salvador, distribution centers in Mexico and Panama, a corporate headquarters in the United States, and specialty therapies through BioStatera. One network, one mission.
Three disciplines, one continuum
Parenteral & devices
GMP-certified parenteral and device production in Argentina (Pilar, since 2017 — US$19.8M expansion completed 2024, with more underway) and El Salvador (brand-new FDA-approved plant, 2025) — the technical core of the group.
Medical devices & hospital pharma
Owned and partner brands reaching hospitals and pharmacies throughout Latin America and the United States — via Mexico's 250,000+ sq ft hub and the Panama center serving Central America and the Caribbean.
BioStatera specialty therapies
Licensed specialty therapies in oncology, pain, hospital care, and rare disease — delivered across Latin America through BioStatera.
What's next
A team of more than 20 is putting AI to work across Grupo Jayor — sharpening how we manufacture, distribute and deliver.
People on our dedicated AI team
Focused on optimizing the group end to end.
Brand universe
From umbrella brands to hospital generics, devices, and specialty therapies — every brand is built, manufactured, or curated to the group's standard.
Browse the portfolio
Umbrella Brands
Umbrella Brands
Umbrella Brands
Umbrella Brands
Umbrella Brands
Salbutamol sulfate · 100 mcg — Bronchodilator
Beclometasone dipropionate — Inhaled Corticosteroid
Salbutamol · 100 mcg/dose — Bronchodilator
Ceftriaxone · 500 mg (IM) / 1 g (IV) — Cephalosporin Antibiotic
Azithromycin · 200 mg/5 mL — Macrolide Antibiotic
Cefotaxime · 1 g — Cephalosporin Antibiotic
Ceftazidime · 1 g — Cephalosporin Antibiotic
Cefepime · 1 g — Cephalosporin Antibiotic
Meropenem · 500 mg / 1 g — Carbapenem Antibiotic
Imipenem + Cilastatin · 500/500 mg — Carbapenem Antibiotic
Paracetamol · 1 g/100 mL IV — Analgesic
Paracetamol · 500 mg/50 mL — Analgesic
Omeprazole · 40 mg/10 mL IV — Proton Pump Inhibitor
Bisoprolol fumarate · 5 mg — Beta-Blocker
Dapagliflozin · 10 mg — SGLT2 Inhibitor
Ondansetron · 8 mg/4 mL — Antiemetic
Tadalafil · 20 mg oral gel — Erectile Dysfunction
Lactulose · 667 mg/mL — Osmotic Laxative
Sodium chloride 0.9% — Nasal Rinse
Medicines
Medical Devices
Licensed Specialty Therapy
Distributed Products
Distributed by Grupo Jayor Panamá
Distributed Products
Distributed by Grupo Jayor Panamá
Official directory
Every operating entity, with a verified path to its legitimate site. Each country site is the authority for its own market.
Operating entities
Laboratorios Biogalenic, S.A. de C.V.
Manufacturing — FDA-approved plant (2025)
Heritage origins
Where it all began — honored founding chapters that carry no active commercial site.
Venezuela
Grupo Jayor (origins)
Founding origin (1991)